Ana Garza Avila, M.D., MSC
Pulmonary Disease Physician in San Antonio, Texas.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 9,271 in Pulmonary Disease Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Source: CMS Medicare Part D Prescriber Public Use File, 2023
What the federal data shows
Ana Garza Avila, M.D., MSC filed 635 Medicare Part D claims in 2023 as a Pulmonary Disease Physician in San Antonio, Texas, prescribing 0% generic.
- 635
- Part D claims, 2023
- 0%
- generic prescribing
- Likely
- board-certified (heuristic)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Ana Garza Avila, M.D., MSC's Medicare Part D volume vs every U.S. prescriber
Total Medicare Part D claims, 2023, across all CMS prescribers nationally
635 Top 31% higher than 69% of 1,370,886 prescribers
Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source CMS Medicare Part D Prescriber Public Use File · 2023
Ana Garza Avila, M.D., MSC practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + 1 hospital affiliation - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Ana Garza Avila, M.D., MSC?
Quality data not reportedPrimary specialty
Medicare Part D claims
Specialty distribution in Texas
How Pulmonary Disease Physician compares to other specialties among Texas providers
Pulmonary Disease Physician ranks #91 among Texas's specialties (0.1% of in-state providers)
Each bar is a specialty's share of the Texas provider total, by primary NUCC taxonomy. The highlighted bar is Pulmonary Disease Physician; the long tail of smaller specialties is omitted for legibility.
Board certification
Not published by CMS
CMS does not publish a per-provider board-certification field in NPPES. PlainDoctor does not have a reliable per-specialty certification rate to show for Pulmonary Disease Physician. Verify directly:
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Ana Garza Avila, M.D., MSC appears in the CMS NPPES registry as a Pulmonary Disease Physician provider holding M.D., MSC credentials at 4458 MEDICAL DR STE 505, San Antonio, TX, 78229, with a listed phone of (210) 690-7400. NPI 1871738385 was issued on 12/11/2008.
Medicare Part D records for calendar year 2023 show 635 prescription claims written by this provider, covering 120 Medicare beneficiaries and totaling roughly $760K in drug spend, split 54% brand-name and 0% generic by claim count.
Pulmonary Disease Physician is a mid-sized specialty nationwide, with 9,271 enrolled providers across 53 states and an average of 1,457 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline.
Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist, always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1871738385 |
|---|---|
| Specialty | Pulmonary Disease Physician |
| Credentials | M.D., MSC |
| Gender | Female |
| NPI Issued | 12/11/2008 |
Verify this provider's license
PlainDoctor pulls this profile from the CMS NPPES public registry. Confirm Ana Garza Avila, M.D., MSC's current license status, disciplinary history, and board certifications with the Texas Medical Board in Texas before relying on this page for a clinical or care decision.
How we sourced this profile
Profile fields combine the CMS NPPES monthly snapshot (provider directory, taxonomy, and address) with calendar-year 2023 Medicare Part D and MIPS public-use files when records are present. NPI 1871738385 is the unique 10-digit identifier CMS uses to link Garza Avila across every Medicare, Medicaid, and HIPAA-covered transaction. Read full methodology →
Hospital and facility affiliations
Facilities where Ana Garza Avila, M.D., MSC bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" - a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.
Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).
Industry payments received (2024) - CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Ana Garza Avila, M.D., MSC. Source: openpaymentsdata.cms.gov.
Total received
$692
Largest payer
AstraZeneca Pharmaceuticals LP
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
License & disciplinary context - Texas TMB 2023 annual report
Aggregate state board data only, NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~77K Texas medical licensees in 2023 - they are NOT specific to Ana Garza Avila, M.D., MSC. To verify Ana Garza Avila, M.D., MSC's current license status, search the TMB public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.
TMB publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Texas disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.
Brand vs generic prescribing mix · Brand-heavy
54% brand-name claims vs 0% generic, on 635 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
Prescribing Breakdown
- 30-Day Fills
- 907
- Total Day Supply
- 24,086
- Brand vs Generic
- 54% brand / 0% generic
- Brand Drug Cost
- $754K
- Antibiotic Claims
- 57
Patient Demographics
- Average Patient Age
- 73.9 years
- Avg HCC Risk Score
- 2.24
- Gender Split
- 67% female / 33% male
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What Ana Garza Avila, M.D., MSC prescribes most
Top Medicare Part D drugs by claim count, 2023
- Trelegy Ellipta
Trelegy Ellipta
99 claims
- Albuterol Sulfate …
Albuterol Sulfate Hfa
74 claims
- Azithromycin
Azithromycin
49 claims
- Prednisone
Prednisone
45 claims
- Fluticasone Propio… 38
Fluticasone Propionate
38 claims
- Montelukast Sodium 31
Montelukast Sodium
31 claims
- Ofev 30
Ofev
30 claims
- Breztri Aerosphere 27
Breztri Aerosphere
27 claims
| Drug | Claims |
|---|---|
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 99 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 74 |
| Azithromycin | 49 |
| Prednisone | 45 |
| Fluticasone Propionate | 38 |
| Montelukast Sodium | 31 |
| Ofev Nintedanib Esylate | 30 |
| Breztri Aerosphere Budesonide/Glycopyr/Formoterol | 27 |
| Symbicort Budesonide/Formoterol Fumarate | 25 |
| Breo Ellipta Fluticasone/Vilanterol | 21 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Pulmonary Disease Physician Overview
How Ana Garza Avila, M.D., MSC fits within the Pulmonary Disease Physician landscape nationally.
Ana Garza Avila, M.D., MSC's 635 claims are below the specialty average of 1,457.
Nearby Pulmonary Disease Physician Providers in Texas
Other clinicians with the same primary specialty enrolled in Texas, drawn from the same CMS NPPES roster as Garza Avila.
Compare Pulmonary Disease Physician nationally: see state-by-state distribution →
Before you book an appointment
Use this federal record as your verification checklist, not as a recommendation.
- Confirm the NPI record is current in the official CMS registry, providers update their own NPPES details, and moves can lag. Verify this NPI
- Check the active license and any disciplinary history with the Texas medical board, federal registration is not a license check. Credential verification guide
- Weigh a second option: compare this provider with a nearby Pulmonary Disease Physician peer on Medicare volume and prescribing patterns. Compare providers
Medicare Part D and MIPS figures describe practice patterns in federal programs only, they are not quality ratings, and PlainDoctor does not rate, rank, or recommend providers.
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
Explore Texas
Frequently Asked Questions
What is Ana Garza Avila, M.D., MSC's specialty? ▼
How much does Ana Garza Avila, M.D., MSC prescribe under Medicare Part D? ▼
Where is Ana Garza Avila, M.D., MSC located? ▼
What is Ana Garza Avila, M.D., MSC's NPI number? ▼
Does Ana Garza Avila, M.D., MSC prescribe more brand-name or generic drugs? ▼
How many Pulmonary Disease Physician providers are there in the US? ▼
What drugs does Ana Garza Avila, M.D., MSC prescribe most often? ▼
Does Ana Garza Avila, M.D., MSC accept Medicare? ▼
How can I verify Ana Garza Avila, M.D., MSC's credentials? ▼
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology